Mackay Clinical School
Leanne Hall
- Senior Research Officer
- leanne.hall@jcu.edu.au
Kristiana Reitano
- Academic Advisor
- kristiana.pederick@jcu.edu.au
Veronica Stanganelli
- Senior Lecturer - Psychiatry
- veronica.stanganelli@jcu.edu.au
Outcomes of SGLT-2 Inhibitor induced Euglycaemic Diabetic Ketoacidosis in North Queensland Intensive Care Units: a Retrospective Cohort Study
This study will examine all ICU outcomes, including but not limited to; mortality, length of stay, use of ventilator, pertaining to SGLT-2 inhibitor induced euglycaemic ketoacidosis over a period of 8 years at the nominated study sites. A secondary aim will be to compare these findings to ICU outcomes of diabetic ketoacidosis patients, sex/age/co-morbidity matched. The data will be analysed to primarily determine differences between both groups, with the aim to develop an understanding of the unique natural history and risk factors of euglycaemic ketoacidosis.
Electronic medical record quaity impact (eMEDI-QI) Study (Old ID 27069)
This study involves application of a daa extraction tool to detect patients at risk for familial hypercholesterolaemia (FH). People with FH are at inceased risk of premature death from coronary artery diseases. The dominent genetic natgure means at least one parent of the patient will have FH, and 50% and 25% chance of their siblings and children having FH respectively. It's estimated only 10% of patients are currently identified. The aim is to identify patients with FH and target the 50% of first-degree relatives in families with FH. Identifying patients with FH benefits with patient, siblings, parents and future generations.
Outcomes of SGLT-2 Inhibitor induced Euglycaemic Diabetic Ketoacidosis in North Queensland Intensive Care Units: a Retrospective Cohort Study
This study will examine all ICU outcomes, including but not limited to; mortality, length of stay, use of ventilator, pertaining to SGLT-2 inhibitor induced
euglycaemic ketoacidosis over a period of 8 years at the nominated study sites. A secondary aim will be to compare these findings to ICU outcomes of
diabetic ketoacidosis patients, sex/age/co-morbidity matched. The data will be analysed to primarily determine differences between both groups, with the
aim to develop an understanding of the unique natural history and risk factors of euglycaemic ketoacidosis.
Outcomes of SGLT-2 Inhibitor induced Euglycaemic Diabetic Ketoacidosis in North Queensland Intensive Care Units: a Retrospective Cohort Study
This study will examine all ICU outcomes, including but not limited to; mortality, length of stay, use of ventilator, pertaining to SGLT-2 inhibitor induced
euglycaemic ketoacidosis over a period of 8 years at the nominated study sites. A secondary aim will be to compare these findings to ICU outcomes of
diabetic ketoacidosis patients, sex/age/co-morbidity matched. The data will be analysed to primarily determine differences between both groups, with the
aim to develop an understanding of the unique natural history and risk factors of euglycaemic ketoacidosis.
Australian women’s self-perceived barriers to participation in cervical cancer screening: a systematic review
- 2020
- Researchers:Leanne HallClare Heal
Rheumatic heart disease in pregnancy and neonatal outcomes: a systematic review and meta-analysis
- 2021
- Public Library of Science
- Researchers:Leanne HallClare Heal
International comparison of guidelines for management of impetigo: a systematic review
- 2022
- Oxford University Press
- Researchers:Leanne HallClare Heal
Risk factors for low back pain outcome: Does it matter when they are measured?
- 2022
- John Wiley & Sons Ltd
- Researchers:Leanne Hall
Start Date:
01 Jan 2009
End Date:
01 Jan 2012
Start Date:
01 Jan 2003
End Date:
01 Jan 2006
Start Date:
01 Jan 2018
Start Date:
01 Jan 2009
Start Date:
01 Jan 2024
Start Date:
01 Jan 2017
End Date:
01 Jan 2023
Start Date:
01 Jan 2011
End Date:
01 Jan 2023
Start Date:
01 Jan 2012
End Date:
01 Jan 2013
Start Date:
01 Jan 2009
